Life Science Big News Roundup: Lexaria and Hill Street Enter Global Manufacturing & Licensing Partnership; Cardiol to Present at Canaccord Genuity 39th Annual Growth Conference Life Science Investing News
Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union Pharmaceutical Investing
Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference Cannabis Investing News
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for THOR-707 Biotech Investing
Lexaria Bioscience and Hill Street Beverage Co. Enter Global Manufacturing & Licensing Partnership Cannabis Investing News
Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
